RXKINETIX AND INDIAN IMMUNOLOGICALS COLLABORATE ON DEVELOPMENT OF THERMOSTABLE HEPATITIS B VACCINES
RxKinetix Inc., a specialty pharmaceutical company developing new therapeutics
focused on un-met needs in oncology care, and Indian Immunologicals Ltd, a leading
manufacturer of veterinary and human vaccines, today announced they will collaborate
in the development of thermostable Hepatitis B vaccines with improved stability
at non-refrigerated temperatures. This project is funded by a grant awarded
to RxKinetix from the Foundation for the National Institutes of Health through
the Grand Challenges in Global Health Initiative.